Shigella on the Rise: A Sexually Transmitted Gut Infection Turns into a UK Public Health Challenge

A recent study has brought into sharper focus a troubling trend: a gut infection called shigella is increasingly being transmitted through sexual networks in the UK. Experts describe this as a “distinct public health threat,” signaling that prevention and response efforts need to adapt to this evolving pattern. Here’s what this means, why it matters, and how communities and health services can respond.

What shigella is and why it’s so contagious

Shigella is a bacterium that causes shigellosis, a gastroenteritis characterized by diarrhea (often bloody), abdominal cramps, fever, and nausea. The illness can be uncomfortable and, in some cases, serious, especially for young children, older adults, and people with weakened immune systems. What makes shigella particularly concerning is its low infectious dose—very few bacteria can trigger infection. This high contagiousness helps explain why outbreaks can spread quickly once the bacteria enters a susceptible population.

Sexual transmission: a shift in how the infection spreads

Traditionally associated with fecal-oral routes in broader settings, shigella has also been documented as being transmitted through sexual activity, especially practices that involve close contact with fecal matter. In the UK, researchers have observed transmission clusters that map onto specific sexual networks, underscoring that shigella is not just a general food- or water-borne problem but a communicable infection within certain communities. The key takeaway is not stigma, but targeted awareness: safe-sex practices and hygiene play a crucial role in breaking transmission chains.

Why this constitutes a distinct public health threat

• : When an infection takes hold within defined social or sexual networks, outbreaks can amplify rapidly, challenging traditional public health approaches that rely on broad population-level trends.
• : Shigella can be resistant to common antibiotics. This complicates treatment and heightens the importance of appropriate antibiotic stewardship and susceptibility testing to guide therapy.
• : Detecting and tracking cases among sexually active populations requires strong cooperation between sexual health services, laboratories, and public health agencies, plus accessible, stigma-free testing.
• : While anyone can be affected, those with compromised immunity or chronic health conditions face higher risks of complications, making rapid identification and care essential.

What readers and services can do now

• : Persistent diarrhea (often with blood), stomach cramps, fever, and dehydration warrant prompt medical evaluation, especially if you’ve had recent sexual activity or contact with someone who is ill.
• : If you experience prolonged symptoms, visit a sexual health clinic or GP. Tell clinicians about recent sexual activity so they can consider shigella in the differential diagnosis and arrange appropriate tests.
• : Use barrier protections during sexual activity that involves the anal or rectal area, avoid sex when symptomatic, and wash hands and sex toys thoroughly after use to reduce transmission risk.
• : In outbreak-affected settings, testing and, where appropriate, notifying recent partners can help curb spread while maintaining privacy and reducing stigma.
• : If antibiotics are prescribed, complete the course as directed and discuss any side effects or concerns with your clinician, especially in the context of rising resistance.

The path forward

Addressing this threat requires a coordinated approach: enhanced surveillance, rapid access to testing in sexual health services, and clear guidance on safe-sex practices tailored to the realities of transmission in networks where shigella is spreading. Public health messaging should be factual, non-stigmatizing, and accessible, encouraging people to seek care without fear of judgment. While vaccines for shigella are not yet standard, ongoing research and improved outbreak responsiveness offer hope. By combining vigilance, education, and compassionate healthcare, the UK can curb transmission and protect communities from this increasingly distinct public health challenge.